Develops drugs for rare skin diseases.
Dec 2025Revenue $19.4M/yrExpenses $26.9M/yr
No trend
Figures by year
When will Sol-Gel Technologies be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $19.4M and expenses $26.9M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $19.4M | $26.9M | −$7.54M |
| Dec 2024 | $11.5M | $23.6M | −$12.0M |
| Dec 2023 | $1.55M | $30.9M | −$29.3M |
| Dec 2022 | $3.88M | $20.1M | −$16.2M |
| Dec 2021 | $31.3M | $28.3M | $2.96M |
| Dec 2020 | $8.77M | $39.0M | −$30.2M |
| Dec 2019 | $22.9M | $48.9M | −$25.9M |
| Dec 2018 | $129K | $33.6M | −$33.5M |
| Dec 2017 | $174K | $31.8M | −$31.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.